Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

anticancer derivatives

  • You have access
    The Privileged Scaffold Quinoline in Derivatives With Anticancer Potential Mediated by Late Apoptosis
    DENISE DIEDRICH, ELENILSON F. SILVA, JULIA B. WILLIG, THAÍS C. RUARO, NÁDIA M.G. COUTO, MICKAEL JEAN, GLORIA N.S. SILVA, DIOGO A. PILGER, ALINE R. ZIMMER, PIERRE V. WEGUE and SIMONE C.B. GNOATTO
    Anticancer Research March 2026, 46 (3) 1475-1487; DOI: https://doi.org/10.21873/anticanres.18042
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire